Peppermint Oil as a Treatment for Children With Bladder and Bowel Dysfunction
Bladder and Bowel Dysfunction
About this trial
This is an interventional treatment trial for Bladder and Bowel Dysfunction
Eligibility Criteria
Inclusion Criteria: Children aged 8-17 years and weighing 30kg or more with non-neurogenic bladder and bowel dysfunction who have failed behavioral therapy. Behavioral therapy, or also termed standard urotherapy, is defined as encompassing the following components [15]: Information and demystification; instruction on avoidance of holding maneuvers, regular bowel habits, proper voiding posture; lifestyle advice encompassing balanced fluid intake and diet, diminished caffeine, regular bladder and bowel emptying patterns; registration of symptoms and voiding habits with bladder diaries or frequency-volume charts; support and encouragement via regular follow up with caregiver. Failure of behavioral therapy is defined as no symptomatology improvement after adherence to behavioral therapy after 6 weeks. Participants must be able to swallow pills Exclusion Criteria: Patients with neurogenic bladder, tethered cord, Society of Fetal Urology grade 3-4 hydronephrosis, vesicoureteral reflux, learning disabilities, or those who have undergone surgical therapy for bladder and bowel dysfunction will be excluded. Patients on medical therapy with oxybutynin within the last 30 days. Patients with hiatal hernia, severe gastrointestinal reflux or gallbladder disorders or on medications for these conditions will be excluded. Patient weighing less than 30 kg.
Sites / Locations
- Children's Hospital, Orange County
Arms of the Study
Arm 1
Experimental
Peppermint Oil
Peppermint oil will be provided free of charge to participants under the trademark Pepogest produced by the maker Nature's Way® (dosage 0.2 mL, 181 mg peppermint oil).